Dedicated to Quickly & Accurately Diagnosing Patients With Low Saliva Flow
Boka Sciences, headquartered in Utah, is focused on quickly and accurately diagnosing patients who suffer from xerostomia (dry mouth) and other diseases that affect saliva flow. The company is developing a portfolio of products based on its proprietary Bokaflo system.
Our first product, BokaFlo, allows the clinician to diagnose xerostomia—a condition that affects an estimated 60-70 million Americans.
BokaFlo is quick, inexpensive, easy to use, and accurate.
FDA Registered
BokaFlo was FDA registered in September 2018.
BokaFlo is also clinically tested and proven to accurately measure salivary flow rate.
Partners
Meet Our Team
Grant Donovan, MBA
President
Grant is a proven entrepreneur with successful experience building and mentoring startups. He has run companies involved in international shipping, finance, and product development using his skills in getting ideas to market. He has been a strategic director of high growth companies including a NYSE listed turnaround. Grant has an engineering degree from the University of Vermont and a Stanford MBA.
Porter Jones, MD
Chief Executive Officer
Dr. Porter Jones founded and was CEO of a chain of medical and dental clinics in Sao Paulo. Prior, Dr. Jones spent 4 years at Hospital Albert Einstein where he managed the oncology department as well as the medical practice division. He currently is a senior medical advisor at MedPass and sits on the board of Dr. Porto. Dr. Jones is a graduate of the University of Utah School of Medicine and has an MBA from Harvard Business School.
Frank Foster
Chairman & Investor
Frank has served as the Managing General Partner of the Gideon Hixon Fund since 2004 and a General Partner since 1990. He is also a Managing Director of DFJ Frontier, a Draper Fisher Jurvetson affiliated venture capital fund with $80M under management focused on seed and early stage technology companies on the west coast. Previously, he was the CEO and Executive Chairman of Prolacta Bioscience. Frank received his MBA from The Harvard Business School and a BA cum laude from Harvard University.
Branden Rosenhan, MD
Board Member
Dr. Branden Rosenhan is a pulmonary and critical care physician and Founder and Director of PenBlade LLC. Dr. Rosenhan is a graduate from Arizona State University and the University of Utah School of Medicine. He completed a residency in Internal Medicine and Pediatrics and a fellowship in Pulmonary and Critical Care. Dr. Rosenhan currently serves as a senior medical advisor and board member for Boka Sciences.
Meet Our Team
Grant Donovan, MBA
President
Grant is a proven entrepreneur with successful experience building and mentoring startups. He has run companies involved in international shipping, finance, and product development using his skills in getting ideas to market. He has been a strategic director of high growth companies including a NYSE listed turnaround. Grant has an engineering degree from the University of Vermont and a Stanford MBA.
Porter Jones, MD
Chief Executive Officer
Dr. Porter Jones founded and was CEO of a chain of medical and dental clinics in Sao Paulo. Prior, Dr. Jones spent 4 years at Hospital Albert Einstein where he managed the oncology department as well as the medical practice division. He currently is a senior medical advisor at MedPass and sits on the board of Dr. Porto. Dr. Jones is a graduate of the University of Utah School of Medicine and has an MBA from Harvard Business School.
Frank Foster
Chairman & Investor
Frank has served as the Managing General Partner of the Gideon Hixon Fund since 2004 and a General Partner since 1990. He is also a Managing Director of DFJ Frontier, a Draper Fisher Jurvetson affiliated venture capital fund with $80M under management focused on seed and early stage technology companies on the west coast. Previously, he was the CEO and Executive Chairman of Prolacta Bioscience. Frank received his MBA from The Harvard Business School and a BA cum laude from Harvard University.
Branden Rosenhan, MD
Board Member
Dr. Branden Rosenhan is a pulmonary and critical care physician and Founder and Director of PenBlade LLC. Dr. Rosenhan is a graduate from Arizona State University and the University of Utah School of Medicine. He completed a residency in Internal Medicine and Pediatrics and a fellowship in Pulmonary and Critical Care. Dr. Rosenhan currently serves as a senior medical advisor and board member for Boka Sciences.
Interested in Learning more about BokaFlo
Please contact us for more information